Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study

Patients affected by severe coronavirus induced disease-2019 (Covid-19) often experience hypoxemia due to alveolar involvement and endothelial dysfunction, which leads to the formation of micro thrombi in the pulmonary capillary vessels. Both hypoxemia and a prothrombotic diathesis have been associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Viecca, Maurizio, Radovanovic, Dejan, Forleo, Giovanni Battista, Santus, Pierachille
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244436/
https://www.ncbi.nlm.nih.gov/pubmed/32450344
http://dx.doi.org/10.1016/j.phrs.2020.104950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244436/
https://www.ncbi.nlm.nih.gov/pubmed/32450344
http://dx.doi.org/10.1016/j.phrs.2020.104950

Ejemplares similares